Question

I am a breastfeeding mother and i want to know if it is safe to use HSDB 3232? Is HSDB 3232 safe for nursing mother and child? Does HSDB 3232 extracts into breast milk? Does HSDB 3232 has any long term or short term side effects on infants? Can HSDB 3232 influence milk supply or can HSDB 3232 decrease milk supply in lactating mothers?

HSDB 3232 lactation summary

HSDB 3232 is safe in breastfeeding
  • DrLact safety Score for HSDB 3232 is 1 out of 8 which is considered Safe as per our analyses.
  • A safety Score of 1 indicates that usage of HSDB 3232 is mostly safe during lactation for breastfed baby.
  • Our study of different scientific research also indicates that HSDB 3232 does not cause any serious side effects in breastfeeding mothers.
  • Most of scientific studies and research papers declaring usage of HSDB 3232 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About HSDB 3232 usage in lactation

Because of a high plasma protein binding capacity, excretion into breast milk seems to be unlikely. A report failed to find any trace of HSDB 3232 in the breast milk. No side effects in breastfed infants from treated mothers have been found. Based on a low oral bioavailability, concentration in the infant's plasma should be nil or low, except in premature and newborn infants with a increased intestinal absorption capacity. Since it has a vermifuge action on Ascaris worms (migration of alive worms) should be carefully used in the tropics, Reportedly, one case of inhibition of mother's milk production was found that was not confirmed in later reports. WHO's Eleventh Model List of Essential Drugs 2002: Compatible with breastfeeding.

Answer by DrLact: About HSDB 3232 usage in lactation

Limited data indicate that HSDB 3232 is poorly excreted into breastmilk and poorly absorbed orally. Reports on the use of HSDB 3232 during breastfeeding have found no adverse reactions in breastfed infants. There are rare case reports of a decrease in milk supply following use of HSDB 3232, but no convincing evidence that these were caused by the drug. No special precautions are required.

HSDB 3232 Side Effects in Breastfeeding

A case series reported 45 nursing mothers who took HSDB 3232 in doses ranging from 100 mg once to 200 mg twice daily for 3 days. About half took 100 mg repeated once after 7 to 14 days. Thirty-three of the infants were exclusively breastfed with ages ranging from 1 to 30 weeks of age. Eight of the 12 partially breastfed infants were over 20 weeks of age. None of the infants were reported by their mothers to have had any adverse reactions.[3]

HSDB 3232 Possible Effects in Breastfeeding

A nursing mother who was 13 weeks postpartum was taking oral metronidazole 250 mg three times daily. Milk production seemed to be unaffected. On the eighth day of therapy she passed a roundworm. Metronidazole was discontinued and oral HSDB 3232 100 mg twice daily was started. The patient was "tense" for a few days after passing the worm. On the second day of HSDB 3232 treatment, milk production dropped markedly and she began supplementation with formula. By day 7, milk production had ceased. The authors suggested that HSDB 3232 might have caused the drop in milk production, but offered no further evidence other than the temporal relationship.[4] Four patients were treated with oral HSDB 3232 100 mg twice daily for 3 days beginning the first day postpartum. Two had pinworm (), 1 had roundworm () and 1 had hookworm () infestations. All breastfed successfully.[2] One author reported information received by personal communication from the manufacturer stating that no inhibition of lactation was noted after a single 100 mg oral dose of HSDB 3232 to a nursing mother (time postpartum not stated).[1] In a case series reported 45 nursing mothers who took HSDB 3232 in doses ranging from 100 mg once to 200 mg twice daily for 3 days, one mother reported a slight decrease in milk production.[3]

Alternate Drugs

Cefoxitin(Safe)
Capreomycin(Low Risk)
Rifaximin(Safe)
Gatifloxacin(Low Risk)
Indinavir(Unsafe)
Lindane(Unsafe)
Cefotetan(Safe)
Ertapenem(Safe)
Econazole(Safe)
Enoxacin(Low Risk)
Ofloxacin(Safe)
Zidovudine(Low Risk)
Doxycycline(Low Risk)
Famciclovir(Low Risk)
Amikacin(Safe)
Neomycin(Safe)
Cefixime(Safe)
Tenofovir(Safe)
Demeclocycline(Low Risk)
Erythromycin(Low Risk)
Nafcillin(Safe)
Cefepime(Safe)
Clindamycin(Low Risk)
Efavirenz(Unsafe)
Moxifloxacin(Low Risk)
Didanosine(Unsafe)
Valganciclovir(Low Risk)
Cefdinir(Safe)
Saquinavir(Unsafe)
Methicillin(Low Risk)
Ganciclovir(Low Risk)
Cefazolin(Safe)
Primaquine(Low Risk)
Malathion(Low Risk)
Acyclovir(Safe)
Meropenem(Safe)
Ritonavir(Unsafe)
Naftifine(Safe)
Cefaclor(Safe)
Atovaquone(Low Risk)
Quinine(Safe)
Abacavir(Safe)
Lomefloxacin(Low Risk)
Nevirapine(Low Risk)
Linezolid(Low Risk)
Levofloxacin(Low Risk)
Kanamycin(Safe)
Nelfinavir(Unsafe)
Amantadine(Low Risk)
Cefprozil(Safe)
Aztreonam(Safe)
Dapsone(Low Risk)
Pyrantel(Safe)
Lindane(Unsafe)
Primaquine(Low Risk)
Malathion(Low Risk)
Atovaquone(Low Risk)
Quinine(Safe)
Pyrantel(Safe)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.